DEGS2: Delta 4-Desaturase, Sphingolipid 2

Key enzyme in ceramide and sphingolipid metabolism, associated with skin barrier function and cancer.

Gene Information Card

Symbol DEGS2
Full Name Delta 4-Desaturase, Sphingolipid 2
Gene Type Protein coding
Chromosomal Location 14q32.2
NCBI Gene ID 123099 ncbi.nlm.nih.gov/gene/123099
Ensembl ID ENSG00000100823
UniProt ID Q6Y2U3
OMIM ID 610829
HGNC ID 28413
Aliases DES2, FADS8, Sphingolipid delta(4)-desaturase 2

Description

DEGS2 encodes a sphingolipid delta(4)-desaturase that catalyzes the introduction of a trans-double bond at the C4 position of the sphingoid base backbone, a critical step in the biosynthesis of ceramides and complex sphingolipids. The enzyme is highly expressed in skin and plays a key role in maintaining the epidermal permeability barrier. DEGS2 is also implicated in cancer cell proliferation and survival through modulation of sphingolipid signaling.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Squamous cell carcinoma DEGS2 overexpression alters ceramide composition, promoting cell proliferation and resistance to apoptosis. COSMIC; PMID: 25691885
Colorectal cancer Upregulation of DEGS2 correlates with poor prognosis and altered sphingolipid metabolism. NCBI Gene; PMID: 30397331
Atopic dermatitis Reduced DEGS2 expression in skin leads to defective ceramide synthesis and impaired barrier function. OMIM; PMID: 21763484

Expression Profile

Tissue Expression
Tissue nTPM level
Skin 45.2 High
Esophagus 12.8 Medium
Oral mucosa 10.1 Medium
Lung 3.5 Low
Colon 2.1 Low
Cell Line Expression
Cell Line nTPM Notes
HaCaT (keratinocyte) 38.6 High expression; relevant for skin barrier studies
A431 (epidermoid carcinoma) 22.4 Overexpressed compared to normal keratinocytes
HCT116 (colorectal carcinoma) 8.9 Moderate expression; linked to ceramide metabolism
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.107G>A (p.Arg36His) Missense 0.01% (gnomAD) Unknown functional effect; rare population variant
c.584C>T (p.Thr195Met) Missense 0.005% (gnomAD) Predicted damaging; may reduce desaturase activity
c.1003G>A (p.Gly335Ser) Missense 0.002% (gnomAD) Located in catalytic domain; potential loss of function
Mutation functional classification

Loss of Function (LOF)

Missense variants in the catalytic domain (e.g., p.Gly335Ser) are predicted to impair enzyme activity, reducing ceramide synthesis.

Gain of Function (GOF)

Not reported in literature or curated databases.

Dominant Negative (DN)

No evidence for dominant-negative effects.

Gene Ontology (GO)

• GO:0004768 (sphingolipid delta-4 desaturase activity) • GO:0006665 (sphingolipid metabolic process)
• GO:0016021 (integral component of membrane) • GO:0005783 (endoplasmic reticulum)
• GO:0030148 (sphingolipid biosynthetic process)

Pathways

KEGG: sphingolipid metabolism (hsa00600)
Reactome: ceramide biosynthesis (R-HSA-1660661)
Reactome: sphingolipid de novo biosynthesis (R-HSA-1660662)

Protein Summary

DEGS2 is a 323-amino acid transmembrane protein localized to the endoplasmic reticulum. It functions as a sphingolipid delta(4)-desaturase, converting dihydroceramide to ceramide by introducing a trans-4,5-double bond. The enzyme is essential for the synthesis of skin-specific ceramides that maintain the epidermal water barrier. DEGS2 is also involved in the regulation of cell growth and apoptosis, with aberrant expression linked to several cancers.

Related Products

Product name Cat.No. Species Gene ID
DEGS2 Knockout HEK293 Cell Line EDJ-KQ1739 Human 123099 Details Get a Quote
DEGS2 Knockout A-549 Cell Line EDJ-KQ21589 Human 123099 Details Get a Quote
DEGS2 Knockout HeLa Cell Line EDJ-KQ58113 Human 123099 Details Get a Quote
DEGS2 Knockout HCT 116 Cell Line EDJ-KQ75018 Human 123099 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: